• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume8, Issue4

Assessment of maternal serum alpha-feto protein level in second trimester

    Dr Heena Mir, Dr Saima Sadiq, Dr Shabnam Ara

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 4, Pages 3023-3027

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background:Antenatal care provides numerous benefits that result from clinical and psychosocial interventions. By providing medical services, counseling and investigations, antenatal care can lead to improved health outcome for women and the fetus. The present study was conducted with the aim to assess maternal serum alpha-feto protein (MSAFP) level in second trimester.
Materials & Methods: The present study was conducted in the postgraduate department of Gynaecology and Obstetrics, Lalla Ded Hospital, Government Medical College Srinagar, over a period of one year. This study was conducted in 250 patients with their consent. Blood was taken for estimation of maternal serum alpha-feto-protein.
Results: Maximum patient were in the age group of 28-31 years i.e. 104 (41.6%) followed by 80 patients (32%) in the age group of 24-27 years followed by 35 (14%) patients in the age group of 32-35 years followed by 31 (12.4%) patients in the age group of 20-23 years. Primi was seen in 170, Para 1in 53 and >1 para in 27 patients. The mean of the maternal serum alphafeto protein (overall) was 65.32+33.95. The mean of the maternal serum alphafeto protein in pregnancies with normal outcome was 53.47+25.65. The mean of the maternal serum alphafeto protein in pregnancies with adverse outcome was 92.96+34.99.
Conclusion: Raised serum alpha-fetoprotein levels in second trimester in absence of neural tube defects can be a useful predictor for adverse pregnancy outcome.
Keywords:
    alpha-fetoprotein Primi second trimester
  • PDF (161 K)
  • XML
(2022). Assessment of maternal serum alpha-feto protein level in second trimester. European Journal of Molecular & Clinical Medicine, 8(4), 3023-3027.
Dr Heena Mir, Dr Saima Sadiq, Dr Shabnam Ara. "Assessment of maternal serum alpha-feto protein level in second trimester". European Journal of Molecular & Clinical Medicine, 8, 4, 2022, 3023-3027.
(2022). 'Assessment of maternal serum alpha-feto protein level in second trimester', European Journal of Molecular & Clinical Medicine, 8(4), pp. 3023-3027.
Assessment of maternal serum alpha-feto protein level in second trimester. European Journal of Molecular & Clinical Medicine, 2022; 8(4): 3023-3027.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 38
  • PDF Download: 49
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus